Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro
ContributorsThouverey, Cyril; Caverzasio, Joseph
Published inBoneKEy reports, vol. 4, no. Art. 757
Publication date2015
Affiliation entities
Research groups
Citation (ISO format)
THOUVEREY, Cyril, CAVERZASIO, Joseph. Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro. In: BoneKEy reports, 2015, vol. 4, n° Art. 757. doi: 10.1038/bonekey.2015.126
Main files (1)
Article (Published version)
Identifiers
- PID : unige:81123
- DOI : 10.1038/bonekey.2015.126
Journal ISSN2047-6396
